Polikar R, Kennedy B, Maisel A, Ziegler M, Smith J, Dittrich H, Nicod P
Division of Cardiology, University of California-San Diego Medical Center 92103.
J Am Coll Cardiol. 1990 Jan;15(1):94-8. doi: 10.1016/0735-1097(90)90182-o.
Cardiovascular sensitivity to catecholamines was assessed in 15 patients with hypothyroidism (mean [+/- SEM] thyroxine [T4] index 2.7 +/- 0.5 micrograms/100 ml, thyroid stimulating hormone [TSH] 136.9 +/- 48.3 microU/ml), aged 45 +/- 4 years and in 8 healthy control subjects. The study was repeated in 10 patients with hypothyroidism 4.0 +/- 0.5 months after thyroid replacement therapy (T4 index 9.9 +/- 2.1 micrograms/100 ml, TSH 3.5 +/- 1.3 microU/ml). In addition, basal, average and maximal heart rates were measured using 24 h ambulatory electrocardiographic (ECG) monitoring, and plasma levels of epinephrine and norepinephrine were determined before and after thyroid replacement. Heart rate increased less after bolus injection of 0.8, 1.6 and 3.2 micrograms of isoproterenol in the hypothyroid (10 +/- 2, 15 +/- 2 and 21 +/- 4 beats/min, respectively) than in the euthyroid (16 +/- 3, 22 +/- 3 and 30 +/- 4 beats/min, respectively) state (p less than 0.05). Control subjects reacted similarly to patients receiving thyroid replacement. Basal heart rate (64 +/- 3 versus 68 +/- 3 beats/min, p less than 0.05) and maximal heart rate (116 +/- 5 versus 133 +/- 5 beats/min, p less than 0.05) were lower on 24 h ambulatory ECG monitoring in the hypothyroid than euthyroid state despite higher basal plasma norepinephrine levels (394 +/- 45 versus 315 +/- 45 pg/ml, p less than 0.05). Thus, patients with hypothyroidism display a decreased cardiac chronotropic response to beta-adrenergic stimulation. This may contribute in part to the decreased basal and maximal daily heart rates seen in patients with hypothyroidism, which occurs despite elevated plasma norepinephrine levels.
对15例甲状腺功能减退患者(平均[±标准误]甲状腺素[T4]指数2.7±0.5微克/100毫升,促甲状腺激素[TSH]136.9±48.3微单位/毫升),年龄45±4岁,以及8名健康对照者,评估了心血管系统对儿茶酚胺的敏感性。在10例甲状腺功能减退患者接受甲状腺替代治疗4.0±0.5个月后(T4指数9.9±2.1微克/100毫升,TSH 3.5±1.3微单位/毫升)重复了该研究。此外,使用24小时动态心电图(ECG)监测测量基础、平均和最大心率,并在甲状腺替代前后测定肾上腺素和去甲肾上腺素的血浆水平。甲状腺功能减退患者静脉注射0.8、1.6和3.2微克异丙肾上腺素后心率增加幅度(分别为10±2、15±2和21±4次/分钟)低于甲状腺功能正常状态(分别为16±3、22±3和30±4次/分钟)(p<0.05)。对照者的反应与接受甲状腺替代治疗的患者相似。在24小时动态心电图监测中,甲状腺功能减退状态下的基础心率(64±3次/分钟对68±3次/分钟,p<0.05)和最大心率(116±5次/分钟对133±5次/分钟,p<0.05)低于甲状腺功能正常状态,尽管基础血浆去甲肾上腺素水平较高(394±45对315±45皮克/毫升,p<0.05)。因此,甲状腺功能减退患者对β-肾上腺素能刺激的心脏变时反应降低。这可能部分导致甲状腺功能减退患者基础和每日最大心率降低,尽管血浆去甲肾上腺素水平升高。